- 全部删除
- 您的购物车当前为空
Tertiapin LQ是源自蜜蜂毒素肽tertiapin的肽衍生物,同时也是向内整流钾(Kir)通道的抑制剂。它能够抑制由G蛋白激活的向内整流钾通道1(GIRK1)和GIRK4(即Kir3.1和Kir3.4)组成的异源多聚钾通道,以及向内整流钾通道1(Kir1.1)。在活体内,tertiapin LQ抑制在雪貂中对条件刺激的Purkinje细胞暂停响应。
Tertiapin LQ是源自蜜蜂毒素肽tertiapin的肽衍生物,同时也是向内整流钾(Kir)通道的抑制剂。它能够抑制由G蛋白激活的向内整流钾通道1(GIRK1)和GIRK4(即Kir3.1和Kir3.4)组成的异源多聚钾通道,以及向内整流钾通道1(Kir1.1)。在活体内,tertiapin LQ抑制在雪貂中对条件刺激的Purkinje细胞暂停响应。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | 待估 | 待询 | |
5 mg | 待估 | 待询 | |
10 mg | 待估 | 待询 |
Tertiapin LQ TFA 相关产品
产品描述 | Tertiapin LQ, a peptide derivative of honeybee venom peptide tertiapin, acts as an inhibitor of inwardly rectifying potassium (Kir) channels. Specifically, it targets and inhibits heteromultimeric potassium channels, including those formed by GIRK1 (also known as Kir3.1) and GIRK4 (Kir3.4), as well as inward-rectifier potassium channel 1 (Kir1.1). Its efficaciousness extends to in vivo applications, where it has been observed to suppress the Purkinje cell pause response to conditional stimuli in ferrets. |
别名 | TPNLQ |
分子量 | 2428.03 |
分子式 | C106H179N33O24S4.XCF3COOH |
Sequence | H-Ala-Leu-Cys(1)-Asn-Cys(2)-Asn-Arg-Ile-Ile-Ile-Pro-Leu-Gln-Cys(1)-Trp-Lys-Lys-Cys(2)-Gly-Lys-Lys-NH2 |
Sequence Short | ALCNCNRIIIPLQCWKKCGKK |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
溶解度信息 | H2O: Soluble |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容